VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MLAB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MLABMesa Laboratories, Inc.
$134.63$744M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMLABCash Flow

Mesa Laboratories, Inc. (MLAB) Cash Flow Statement

30Y historyFree accessUpdated daily

Despite inconsistent net income, Mesa generates strong underlying cash flow, evidenced by an operating cash flow of $14.7M in Q1 2027 that exceeds net income by a factor of 5.21.

Income StatementBalance SheetCash FlowRatios

MLAB Cash Flow Statement

Annual statement

MLAB Cash Flow Statement

Mesa Laboratories, Inc. (MLAB) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01Mar'00Mar'99Mar'98Mar'97
Cash from Operations55.67M42.83M46.81M44.13M27.98M39.22M37.07M26.56M30.55M24.81M7.75M16.9M10.82M12.37M11.4M12.49M8.87M5.98M5.08M4.62M4.03M2.31M2.5M3.27M2.9M2.26M1.05M2.33M2.7M2.2M2.4M
Operating CF Margin %-17.19%19.42%20.41%12.77%21.28%27.68%22.57%29.63%25.8%8.27%19.97%15.16%23.47%24.55%31.53%27.03%27.27%23.57%23.6%23.38%19.91%24.91%35.86%31.92%24.95%11.49%26.9%33.33%27.85%30.77%
Operating CF Growth %746.38%-8.5%6.06%57.71%-28.66%5.8%39.59%-13.08%23.13%220.18%-54.15%56.28%-12.58%8.52%-8.7%40.75%48.38%17.83%9.94%14.48%74.85%-7.8%-23.59%12.91%28.45%115.77%-55.08%-13.76%22.73%-8.33%41.18%
Net Income4.8M6.71M-1.97M-254.25M930K1.87M3.27M1.35M7.48M-2.96M11.18M11.17M9.58M9M8.45M7.92M6.18M4.77M4.79M4.61M3.96M2.81M2.31M2.13M2.13M2.03M1.83M2.11M2.1M2.1M1.7M
Depreciation & Amortization-312K23.27M24.53M31.57M33.13M25.07M17.66M12.99M9.43M9.47M8.74M7.17M5.66M3.84M3.43M2.21M1.84M786K788K742K669K93K90K97K115.35K115.09K521.69K332.59K200K200K200K
Stock-Based Compensation-1.52M17.87M13.14M11.94M12.54M11.39M9.27M5.53M4.21M1.67M1.41M1.33M993K840K1.11M464K383K282K276K246M216M97K000000000
Deferred Taxes0-1.29M-72K-28.42M-3.49M128K-3.5M-1.97M-2.47M-2.7M-630K-807K450K-43K-291K-258K-414K92K116K9K-243K37K31K108K31.44K20.57K-107.14K50.45K000
Other Non-Cash Items50.95M1.26M4.28M277.32M1.99M7.96M5.12M11.8M4.01M16.1M93K53K-160K-420K146K350K10K-60K80K-245.75M-215.63M85K40K-65K45K-22K103.97K-12K200K00
Working Capital Changes8.4M-4.99M6.9M5.97M-17.11M-7.19M5.25M-3.14M7.89M3.24M-13.04M-2.01M-5.71M-848K-1.3M1.8M867K111K-975K-991K-723K-811K28K1M580.01K112.06K-1.3M-149.1K200K-100K500K
Change in Receivables-16.42M-3.21M-2.92M4.94M-2.12M-6.75M-647K-1.67M1.59M680K994K-1.96M-2.29M697K-1.51M493K-965K-43M-494M-82M-703M-503M000000000
Change in Inventory-2.68M-4.43M1.15M2.56M-10.18M-1.04M929K414K2.57M2.29M295K-1.2M-3.16M-1.3M-228K1.28M-72K-143K-479K-723K-397K-468K123K285K54.09K-244-501.79K252.19K100K0100K
Change in Payables1.01M-1.2M-388K-97K-1.54M1.37M967K-61K1.09M212K-655K-150K410K754K437K-150K-1K184K123K-84M-33M28M000000000
Cash from Investing-2.8M-3.25M-4.5M-81.31M-9.49M-305.23M-1.99M-185.59M-3.88M-17.18M-18.41M-31.84M-23.37M-23.14M-17.57M-1.42M-20.67M-3.16M-531K-352K-3.53M544K124K-2.13M-64.93K-41.82K-80.05K-4.19M2M-2.3M-200K
Capital Expenditures450K-3.25M-4.25M-2.57M-4.54M-4.43M-1.99M-1.5M-1.26M-2.8M-11.61M-7.73M-2.83M-1.04M-908K-683K-2.65M-3.16M-676K-352K-1.78M-115K-70K-34K-64.93K-41.82K-80.05K-4.1M0-200K-100K
CapEx % of Revenue0.18%1.3%1.76%1.19%2.07%2.4%1.49%1.27%1.22%2.91%12.39%9.13%3.96%1.97%1.96%1.72%8.06%14.43%3.14%1.8%10.32%0.99%0.7%0.37%0.71%0.46%0.88%47.39%-2.53%1.28%
Acquisitions000-78.74M-4.95M-300.79M0-184.1M-4.84M-15.52M-6.8M-24.11M-20.54M-22.76M-16.66M-737K-17.97M000-3M-659M000000000
Investments-------------------------------
Other Investing-3.25M0-250K000015K2.22M1.13M-6.8M-31.84M-20.54M661K-16.66M-737K-56K-3.16B145K-145M-1.75B659M00000-83.13K0-100K-100K
Cash from Financing-43.92M-41.85M-44.51M32.84M-33.33M52.58M146.23M231.28M-21.67M-8.12M10.71M18.62M9.07M12.33M2.98M-7.42M4.88M-1.46M-1.2M-1.84M-1.62M-3.36M-2.32M-1.23M-1.53M-1.07M-1.5M-1.97M-1.4M-500K-200K
Debt Issued (Net)-20.26M-26.75M-42.35M37.5M-36M49M0149.5M-23.63M-8.63M9.55M19M9.75M12.5M4M-6.5M6.5M0000000000-168.69K00-300K
Equity Issued (Net)000000145.94M89.94M5.09M03.51M00-22K-102K721K91K-265K33K-729K-349K-1.81M-1.03M-502K-1.53M-1.07M-1.5M-1.8M-1.3M-500K100K
Dividends Paid-3.53M-3.52M-3.47M-3.45M-3.41M-3.34M-3.17M-2.72M-2.46M-2.41M-2.35M-2.3M-2.18M-1.99M-1.81M-1.65M-1.49M-1.34M-1.27M-1.14M-1.27M-1.55M-1.28M-770K0000000
Share Repurchases00000000-5.09M0000-22K-98K-92K-105K-265K-132K-831K-480K-1.99M-1.16M-800K-1.62M-1.1M-1.54M-1.88M-1.4M-600K0
Other Financing-20.14M-11.58M1.3M-1.22M6.08M6.92M3.46M-5.44M-680K2.92M01.92M1.5M1.84M898K0-227K152K36K29K00040K0000-100K00
Net Change in Cash9.42M-393K-893K-4.7M-16.44M-214.52M182.49M71.19M4.72M-351K125K3.66M-3.54M1.57M-3.19M3.65M-6.92M1.36M3.34M2.42M-1.12M-512K308K-91K1.3M1.15M-532.94K-3.83M-1.4M-500K-200K
Free Cash Flow56.12M39.58M42.31M41.57M23.44M34.79M35.08M25.06M29.29M22.02M-3.85M9.17M7.99M11.33M10.49M11.81M6.23M2.82M4.4M4.26M2.25M2.19M2.43M3.24M2.83M2.21M965.83K-1.77M2.7M2M2.3M
FCF Margin %22.47%15.89%17.56%19.23%10.7%18.87%26.19%21.29%28.4%22.89%-4.12%10.84%11.2%21.49%22.6%29.8%18.97%12.84%20.43%21.8%13.06%18.92%24.21%35.49%31.2%24.49%10.61%-20.49%33.33%25.32%29.49%
FCF Growth %66.78%-6.45%1.79%77.34%-32.63%-0.83%39.98%-14.44%33.05%671.08%-142.02%14.85%-29.51%7.99%-11.11%89.56%121.16%-35.99%3.17%89.34%2.78%-9.87%-24.95%14.3%27.94%129.32%154.46%-165.69%35%-13.04%76.92%
FCF per Share9.757.117.797.724.376.526.855.737.265.84-1.002.442.193.142.923.411.870.861.361.300.700.720.781.030.860.640.26-0.460.650.450.51
FCF Conversion (FCF/Net Income)11.69x6.38x-23.71x-0.17x30.09x20.96x11.32x14.94x4.08x-8.38x0.69x1.51x1.13x1.37x1.35x1.58x1.44x1.25x1.06x1.00x1.02x0.82x1.08x1.54x1.36x1.11x0.57x1.11x1.29x1.05x1.41x
Interest Paid0011.08M4.65M3.48M2.76M2.37M1.63M1.64M1.96M1.38M848K499K133K116K176K141K00000000000000
Taxes Paid005.73M4.59M1.36M3.05M1.37M2.63M5.87M-4.55M5.61M3.95M3.35M4.71M4.78M4.46M3.53M2.5M2.67M2.79M00000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Persistent Earnings-Cash Flow Disconnect

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Robust Cash Conversion Amid Net Losses

Operating cash flow has consistently exceeded net income, with an OCF/NI ratio of 5.21 in Q1 2027, suggesting strong underlying cash generation despite reported losses in multiple recent quarters.

The significant disconnect between net income and operating cash flow, where OCF has been positive in every quarter including periods of net loss (e.g., -$4.1M NI in Q4 2026 vs. $14.0M OCF), indicates heavy reliance on non-cash charges like depreciation and stock-based compensation. This pattern, consistent with the prior analysis of distorted earnings, implies that the company's core operations are cash-generative, but reported profitability is being severely masked by accounting items. Investors should monitor whether this strong cash conversion can persist if non-cash adjustments moderate.

Free Cash Flow Volatility Amid Stable Margins

FCF margin has been volatile, ranging from 1.5% to 28.0% over the past ten quarters, yet has recently stabilized above 20%, indicating strong but inconsistent cash generation relative to revenue.

The erratic FCF margin trajectory, swinging from a low of 1.5% in Q1 2026 to a high of 28.0% in Q3 2025, appears driven primarily by swings in working capital rather than fundamental shifts in operational cash generation. The recent quarters showing FCF margins above 20% suggest the company has achieved a higher cash conversion baseline, but the sharp decline to 6.0% in Q2 2025 underscores the sensitivity to working capital cycles. This volatility complicates forecasting and suggests the company's cash flow is not yet on a stable, predictable growth path.

Working Capital as Primary Cash Flow Driver

Working capital changes have been the dominant factor in operating cash flow volatility, swinging from a $10.0M source in Q3 2026 to a $8.0M use in Q1 2026.

The extreme swings in working capital, which have accounted for the majority of the variance in quarterly operating cash flow, suggest a highly seasonal or lumpy business cycle for inventory and receivables. The large positive working capital contributions in quarters like Q4 2024 ($8.6M) and Q3 2026 ($10.0M) appear to be timing-related releases, which are not sustainable cash sources. This reliance on working capital management for strong OCF quarters, coupled with the prior finding of erratic profitability, indicates the company's cash flow quality is dependent on cyclical collection and payment patterns.

Disciplined Capital Allocation to Dividends

Dividends paid have remained stable at approximately $0.87-0.88 million per quarter, representing a modest but consistent cash outflow that is easily covered by operating cash flow.

The consistent dividend payment, which has grown marginally from $0.864M in Q4 2024 to $0.884M in Q1 2027, indicates a commitment to returning cash to shareholders despite volatile earnings. Given that the dividend is covered by OCF in every quarter (often multiple times over), this deployment does not appear to strain the balance sheet. However, the lack of any share repurchases or significant acquisition activity (only a net $0.961M in Q4 2024) suggests management is prioritizing liquidity and dividend stability over aggressive growth-oriented capital deployment.

Stock-Based Compensation Cash Reality

Stock-based compensation, a non-cash expense added back to operating cash flow, was a massive -$11.1M in Q4 2026, representing a significant future cash obligation via share dilution.

The large negative SBC figure in Q4 2026 is particularly notable because it appears as a debit in the cash flow statement, implying a large non-cash charge to income that was added back. While this temporarily inflates operating cash flow relative to net income, it creates a future economic cost in the form of share dilution. When combined with the volatile depreciation and amortization figures (e.g., -$17.5M in Q4 2026), these non-cash items can obscure the true recurring cash cost of running the business, a point that aligns with the prior analysis of distorted net income.

MLAB — Frequently Asked Questions

Quick answers to the most common questions about buying MLAB stock.

How much cash does Mesa Laboratories, Inc. (MLAB) generate from operations?

Mesa Laboratories, Inc. (MLAB) generated $42.8M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Mesa Laboratories, Inc.'s free cash flow?

Mesa Laboratories, Inc. (MLAB) generated $39.6M in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Mesa Laboratories, Inc.'s capital expenditure (CapEx)?

Mesa Laboratories, Inc. (MLAB) spent $3.3M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Mesa Laboratories, Inc. distribute cash to shareholders?

In 2026, Mesa Laboratories, Inc. (MLAB) returned $3.5M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.